Epstein-Barr virus test: Procedure, results, and interpretation
VIDAS EBV panel, diagnosis of Mononucleosis | bioMérieux Clinical Diagnostics
Microorganisms | Free Full-Text | Epstein-Barr Virus Exploits the Secretory Pathway to Release Virions
Serologic Markers of Epstein–Barr Virus Infection and Nasopharyngeal Carcinoma in Taiwanese Men | NEJM
Pediatric Mononucleosis and Epstein-Barr Virus Infection: Practice Essentials, Background, Pathophysiology
Guilty by association: Epstein–Barr virus in multiple sclerosis | Nature Medicine
Can we vaccinate against Epstein-Barr, the virus you didn't know you had? | Science | The Guardian
CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease: Molecular Therapy - Oncolytics
EBV Genome Mutations and Malignant Proliferations | IntechOpen
Study confirms link between Epstein-Barr virus and multiple sclerosis
Epstein–Barr virus infection in humans: from harmless to life endangering virus–lymphocyte interactions | Oncogene
Epstein Barr Virus Treatment, Companies, Market Trends | Epstein Barr Virus Infographic
Viruses | Free Full-Text | Virological Markers in Epstein–Barr Virus-Associated Diseases
Epstein-Barr virus infection in ulcerative colitis: a clinicopathologic study from a Chinese area - Shu Xu, Haiyang Chen, Xiaoman Zu, Xiuxue Hao, Rui Feng, Shenghong Zhang, Baili Chen, Zhirong Zeng, Minhu Chen,
43 Everything You Need to Know to Interpret Epstein Barr (EBV) Results - Health Mysteries Solved
Frontiers | The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis
Epstein–Barr virus - Wikipedia
Impaired surface marker expression in stimulated Epstein-Barr virus transformed lymphoblasts from Barth Syndrome patients | Scientific Reports
Potential anti-EBV effects associated with elevated interleukin-21 levels: a case report | BMC Infectious Diseases | Full Text
Study suggests Epstein-Barr virus may cause multiple sclerosis | National Institutes of Health (NIH)
B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection | PLOS Pathogens
Viruses | Free Full-Text | How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection
EBV - Nose & Throat Cancer Marker – Beacon Health Screening Centre
Cureus | A Lethal Manifestation of Chronic Active Epstein-Barr Virus Infection: A Case Report | Article
